Current issues in myeloma and plasmacytoma

Current issues highlight some of the latest research into myeloma and plasmacytoma, new therapies becoming available and new drug treatments coming to the market.

Thalidomide as first therapy for myeloma Early reports of the efficacy of thalidomide as initial therapy for myeloma have been confirmed in recently reported data from Texas. As sole therapy, thalidomide brought about partial remission in...
Bortezomib in myeloma Bortezomib is a new proteasome inhibitor that blocks NF-kB-mediated transcription of cytokines, adhesion molecules, angiogenesis factors, anti-apoptotic factors and other factors that contribute to...